These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24292545)
1. Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis. Pissinate K; dos Santos Martins-Duarte É; Schaffazick SR; de Oliveira CP; Vommaro RC; Guterres SS; Pohlmann AR; de Souza W Parasitol Res; 2014 Feb; 113(2):555-64. PubMed ID: 24292545 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil. Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Romand S; Pudney M; Derouin F Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620 [TBL] [Abstract][Full Text] [Related]
4. Pyrimethamine concentrations in serum during treatment of acute murine experimental toxoplasmosis. Weiss LM; Luft BJ; Tanowitz HB; Wittner M Am J Trop Med Hyg; 1992 Mar; 46(3):288-91. PubMed ID: 1558268 [TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model. Martins-Duarte ÉS; de Souza W; Vommaro RC Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807 [TBL] [Abstract][Full Text] [Related]
6. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice. Mahmoud MS J Egypt Soc Parasitol; 1999; 29(3):791-803. PubMed ID: 12561919 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis. Sordet F; Aumjaud Y; Fessi H; Derouin F Parasite; 1998 Sep; 5(3):223-9. PubMed ID: 9772721 [TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii. Romand S; Bryskier A; Moutot M; Derouin F J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193 [TBL] [Abstract][Full Text] [Related]
9. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii. Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii. Abugri DA; Witola WH; Russell AE; Troy RM Chem Biol Drug Des; 2018 Jan; 91(1):194-201. PubMed ID: 28696589 [TBL] [Abstract][Full Text] [Related]
11. Effect of Nigella sativa oil on experimental toxoplasmosis. Mady RF; El-Hadidy W; Elachy S Parasitol Res; 2016 Jan; 115(1):379-90. PubMed ID: 26446086 [TBL] [Abstract][Full Text] [Related]
12. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii. de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805 [TBL] [Abstract][Full Text] [Related]
13. Effect of nitaxozanide and pyrimethamine on astrocytes infected by Toxoplasma gondii in vitro. Galván-Ramírez Mde L; Dueñas Jiménez JM; Rocío Rodríguez Pérez L; Troyo-Sanroman R; Ramírez-Herrera M; García-Iglesias T Arch Med Res; 2013 Aug; 44(6):415-21. PubMed ID: 23973195 [TBL] [Abstract][Full Text] [Related]
14. Treatment of acute Toxoplasma gondii infections in mice with diclazuril or a combination of diclazuril and pyrimethamine. Lindsay DS; Rippey NS; Blagburn BL J Parasitol; 1995 Apr; 81(2):315-8. PubMed ID: 7707217 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis. Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice. Mitchell SM; Zajac AM; Davis WL; Lindsay DS J Parasitol; 2004 Jun; 90(3):639-42. PubMed ID: 15270113 [TBL] [Abstract][Full Text] [Related]